Anti-tumour necrosis factor therapy ameliorates joint disease in a chronic model of inflammatory arthritis [1]

British Journal of Rheumatology

Volumn 36, Issue 10, 1997, Pages 1129-

  Beech, J T ^a   Thompson, S J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; PRISTANE; TN 3 GAMMA1; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTHROPATHY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; INTRAPERITONEAL DRUG ADMINISTRATION; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYMPTOM;

ANIMALS; ANTIBODIES, MONOCLONAL; CRICETINAE; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INJECTIONS, INTRAPERITONEAL; JOINT DISEASES; KNEE JOINT; MICE; MICE, INBRED DBA; SEVERITY OF ILLNESS INDEX; TERPENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030682384     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)